Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Moderna beats Pfizer on long-term protection against hospitalization, study says
18 Sep

Moderna beats Pfizer on long-term protection against hospitalization, study says

By admin 0 Comments

Accumulating research suggests vaccine's superiority, possibly due to dosage level -- 100 micrograms against 30 -- or dosage interval, with Pfizer given 3 weeks apart and Moderna 4

Details
Vote up!
Vote down!

Points: 15

Category: 
Israel & the Region
Moderna
Moderna vaccine
Pfizer-BioNTech vaccine
Pfizer
Johnson & Johnson
CDC Centers for Disease Control
coronavirus
coronavirus vaccine
COVID-19 Delta variant
  • Log in or register to post comments

Author

anon

admin

Hot

  • Mamdani Gains Surprising Hearing from Satmar Leader in NYC Mayoral Race
  • Report: Elon Musk Tackled Treasury Secretary During White House Clash
  • FBI Hunts Down Masked LA Brute Wanted For Hurling ‘Cinderblock’ Rocks At Federal Officers During Riots — AG Bondi Warns: ‘You Can’t Hide’

User login

  • Create new account
  • Request new password

Recent comments

No comments available.